News Ticker

Orthobiologics Market – Global Industry Analysis, Size, Share, Growth and Forecast Report To 2025

Orthobiologics Market Overview:

Orthobiologics helps to heal injured muscles, fractures, tendons and ligaments more quickly. These are made up of naturally occurring body substances such as autologous conditioned serum, autologous blood, bone grafts, stem cells, platelet rich plasma, and growth factors. Therefore, these are commercially available for orthopedic applications such as joint reconstruction, spinal fusion, and sports related injuries.

Browse Full Report @

Rise in number of orthopedic surgeries, rapidly aging population, increasing in adoption of advanced products, and growing demand for minimal invasive procedures are set to drive the global market for orthobiologics. As per the report published by American Academy of Orthopedic Surgeons, in U.S., around 500,000 bone grafting surgeries are performed every year. Of these, almost half of the surgeries are related to spinal fusion. These large number of procedures lead to rise in demand for musculoskeletal tissue donation and a shortage of cadaver material.

Additionally, increased availability of products with high osteoinductive and osteoconductive properties will further contribute to the market growth. An osteoinductive protein provides biophysical stimulation which helps to repair and regenerate bone fractures. Moreover, the high demand for orthobiologics in orthopedic industry coupled with rise in adoption of orthobiologics in different orthopedic applications such as joint reconstruction, trauma, craniomaxillofacial, and spinal fusion.

Request for an in-depth table of contents for this report @

Development of novel products related to bone healing has changed the field of orthopedic treatment. Therefore, major players are highly focused on developing and commercializing technologically advanced products. For instance, in September 2015, Wright Medical Group Inc. obtained premarket approval for its Augment bone graft from FDA. This graft can be used in ankle or hind foot fusion procedures. Similarly, in November 2015, CeraPedics, an orthobiologics company, obtained Premarket Approval (PMA) application for its “i-FACTOR Peptide Enhanced Bone Graft”. This graft can be used for the treatment of degenerative cervical disc related disorders. Thus, introduction of technologically advanced products is set to propel the market growth.

Major players operating in this market are Medtronic plc, Stryker Corporation, Bone Biologics Corp., Orthofix, Inc., Arthrex, Inc., Isto Biologics, Bioventus, NuVasive, Inc., Osiris Therapeutics, Inc., and RTI Surgical, Inc. These companies are highly focused on expanding their geographical presence through establishing strong distribution channels and direct sales network.

Make an inquiry @

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: